Telomerase activity in ovarian tumors

Cancer

Volumn 80, Issue 6, 1997, Pages 1085-1092

  Murakami, Junko ^a   Nagai, Nobutaka ^a   Ohama, Koso ^a   Tahara, Hidetoshi ^a   Ide, Toshinori ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Ovarian tumor; Telomerase activity; Telomere; Tumor marker

Indexed keywords

TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; OVARY TUMOR; PRIORITY JOURNAL; TELOMERE;

ADULT; AGED; BLOTTING, SOUTHERN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE; TELOMERE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030809590     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970915)80:6<1085::AID-CNCR11>3.0.CO;2-4     Document Type: Article

References (32)

1. Blackburn EH. Telomerase. Annu Rev Biochem 1992; 61:113-29.
2. Levy MZ, Allsopp RC, Fucher B, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225:951-60.
3. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-9.
4. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, et al. The RNA component of human telomerase. Science 1995; 269:1236-41.
5. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6.
6. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989; 337:331-7.
7. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87:884-94.
8. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91:2900-4.
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
10. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994; 59:307-15.
11. Kidera Y, Yoshimura T, Ohkuma Y, Iwasaki T, Sugimori H. Establishment and characterization of cell line derived from mucinous cystadeno-carcinoma of human ovary. Acta Obstet Gynec Jpn 1985; 37:1821-4.
12. Japan Society of Obstetrics and Gynecology and The Japanese Society of Pathology. The general rules for clinical and pathological management of ovarian tumors. 1 st edition. Tokyo: Kanahara Press, 1990.
13. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55:3258-62.
14. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1:249-55.
15. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87:895-902.
16. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88:116-22.
17. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55:2734-6.
18. Nouso K, Urabe Y, Higashi T, Nakatsukasa H, Hino N, Ashida K, et al. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Cancer 1996; 78:232-6.
19. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-6.
20. Sommerfeld H-J, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56:218-22.
21. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68:3410-4.
22. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92:4818-22.
23. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival Gynecol Oncol 1995; 56:325-7.
24. Levin L, Lund B, Heintz AP. Advanced ovarian cancer. An overview of multi-variate analysis of prognostic variables with special reference to the role of cytoreductive surgery. Ann Oncol 1993; 4:23-9.
25. Kim JW, Cho YH, Kwon DJ, Kim TE, Park TC, Lee JM, et al. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma. Gynecol Oncol 1995; 57:199-204.
26. Csokay B, Papp J, Besznyak I, Bosze P, Sarosi Z, Toth J, et al. Oncogene patterns in breast and ovarian carcinomas. Eur J Surg Oncol 1993; 19:593-9.
27. Rosen A, Sevelda P, Klein M, Dobianer K, Hruza C, Czerwenka K, et al. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer 1993; 67:1122-5.
28. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995; 86:899-904.
29. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996; 16:53-65.
30. 60Co gamma rays or 4-nitroquinoline 1-oxide. Hum Genet 1996; 97:1-6.
31. Parkinson EK. Do telomerase antagonists represent a novel anti-cancer strategy? Br J Cancer 1996; 73:1-4.
32. Wright WE, Shay JW, Piatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 3:3794-5.